117 related articles for article (PubMed ID: 38838507)
21. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
[TBL] [Abstract][Full Text] [Related]
22. RA-XII, a bicyclic hexapeptidic glucoside isolated from Rubia yunnanensis Diels, exerts antitumor activity by inhibiting protective autophagy and activating Akt-mTOR pathway in colorectal cancer cells.
Wang J; Wang J; Li L; Feng L; Wang YR; Wang Z; Tan NH
J Ethnopharmacol; 2021 Feb; 266():113438. PubMed ID: 33017635
[TBL] [Abstract][Full Text] [Related]
23. Lycorine inhibits cell proliferation, migration and invasion, and primarily exerts
Zhang P; Yuan X; Yu T; Huang H; Yang C; Zhang L; Yang S; Luo X; Luo J
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649853
[TBL] [Abstract][Full Text] [Related]
24. IFN-γ-mediated IRF1/miR-29b feedback loop suppresses colorectal cancer cell growth and metastasis by repressing IGF1.
Yuan L; Zhou C; Lu Y; Hong M; Zhang Z; Zhang Z; Chang Y; Zhang C; Li X
Cancer Lett; 2015 Apr; 359(1):136-47. PubMed ID: 25592039
[TBL] [Abstract][Full Text] [Related]
25. Inhibitor of DNA binding 2 knockdown inhibits the growth and liver metastasis of colorectal cancer.
Liu F; Chen S; Yu Y; Huang C; Chen H; Wang L; Zhang W; Wu J; Ye Y
Gene; 2022 Apr; 819():146240. PubMed ID: 35114275
[TBL] [Abstract][Full Text] [Related]
26. 6-Gingerol induces cell-cycle G1-phase arrest through AKT-GSK 3β-cyclin D1 pathway in renal-cell carcinoma.
Xu S; Zhang H; Liu T; Yang W; Lv W; He D; Guo P; Li L
Cancer Chemother Pharmacol; 2020 Feb; 85(2):379-390. PubMed ID: 31832810
[TBL] [Abstract][Full Text] [Related]
27. TMEM206 promotes the malignancy of colorectal cancer cells by interacting with AKT and extracellular signal-regulated kinase signaling pathways.
Zhao J; Zhu D; Zhang X; Zhang Y; Zhou J; Dong M
J Cell Physiol; 2019 Jul; 234(7):10888-10898. PubMed ID: 30417481
[TBL] [Abstract][Full Text] [Related]
28. Regorafenib suppresses epidermal growth factor receptor signaling-modulated progression of colorectal cancer.
Liu YC; Tsai JJ; Weng YS; Hsu FT
Biomed Pharmacother; 2020 Aug; 128():110319. PubMed ID: 32502841
[TBL] [Abstract][Full Text] [Related]
29. Promethazine inhibits proliferation and promotes apoptosis in colorectal cancer cells by suppressing the PI3K/AKT pathway.
Tan X; Gong L; Li X; Zhang X; Sun J; Luo X; Wang Q; Chen J; Xie L; Han S
Biomed Pharmacother; 2021 Nov; 143():112174. PubMed ID: 34560542
[TBL] [Abstract][Full Text] [Related]
30. Anti-invasive effect and pharmacological mechanism of genistein against colorectal cancer.
Chen X; Wu Y; Gu J; Liang P; Shen M; Xi J; Qin J
Biofactors; 2020 Jul; 46(4):620-628. PubMed ID: 32078221
[TBL] [Abstract][Full Text] [Related]
31. High glucose inhibits autophagy and promotes the proliferation and metastasis of colorectal cancer through the PI3K/AKT/mTOR pathway.
Li F; Wan X; Li Z; Zhou L
Cancer Med; 2024 Jun; 13(11):e7382. PubMed ID: 38872380
[TBL] [Abstract][Full Text] [Related]
32. RasGRF2 promotes migration and invasion of colorectal cancer cells by modulating expression of MMP9 through Src/Akt/NF-κB pathway.
Lu P; Chen J; Yan L; Yang L; Zhang L; Dai J; Hao Z; Bai T; Xi Y; Li Y; Kang Z; Xv J; Sun G; Yang T
Cancer Biol Ther; 2019; 20(4):435-443. PubMed ID: 30359168
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA.
Wang Y; Tang Q; Li M; Jiang S; Wang X
Biochem Biophys Res Commun; 2014 Feb; 444(2):199-204. PubMed ID: 24440701
[TBL] [Abstract][Full Text] [Related]
34. Toosendanin inhibits growth and induces apoptosis in colorectal cancer cells through suppression of AKT/GSK-3β/β-catenin pathway.
Wang G; Feng CC; Chu SJ; Zhang R; Lu YM; Zhu JS; Zhang J
Int J Oncol; 2015 Nov; 47(5):1767-74. PubMed ID: 26398368
[TBL] [Abstract][Full Text] [Related]
35. Withaferin-A suppress AKT induced tumor growth in colorectal cancer cells.
Suman S; Das TP; Sirimulla S; Alatassi H; Ankem MK; Damodaran C
Oncotarget; 2016 Mar; 7(12):13854-64. PubMed ID: 26883103
[TBL] [Abstract][Full Text] [Related]
36. AMP-kinase inhibitor dorsomorphin reduces the proliferation and migration behavior of colorectal cancer cells by targeting the AKT/mTOR pathway.
Ghanaatgar-Kasbi S; Amerizadeh F; Rahmani F; Hassanian SM; Khazaei M; Ferns GA; Avan A
IUBMB Life; 2019 Dec; 71(12):1929-1936. PubMed ID: 31359579
[TBL] [Abstract][Full Text] [Related]
37. Raddeanin A inhibits growth and induces apoptosis in human colorectal cancer through downregulating the Wnt/β-catenin and NF-κB signaling pathway.
Wang Y; Bao X; Zhao A; Zhang J; Zhang M; Zhang Q; Ma B
Life Sci; 2018 Aug; 207():532-549. PubMed ID: 29972765
[TBL] [Abstract][Full Text] [Related]
38. Regulation of HGF-induced hepatocyte proliferation by the small GTPase Arf6 through the PIP
Tsai MT; Katagiri N; Ohbayashi N; Iwasaki K; Ohkohchi N; Ding ST; Kanaho Y; Funakoshi Y
Sci Rep; 2017 Aug; 7(1):9438. PubMed ID: 28842595
[TBL] [Abstract][Full Text] [Related]
39. Uncovering the action mechanism of homoharringtonine against colorectal cancer by using network pharmacology and experimental evaluation.
Qu M; Li J; Yuan L
Bioengineered; 2021 Dec; 12(2):12940-12953. PubMed ID: 34847838
[TBL] [Abstract][Full Text] [Related]
40. The role of PIP5K1A in cancer development and progression.
Yin M; Wang Y
Med Oncol; 2022 Jul; 39(10):151. PubMed ID: 35852640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]